Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Probiotics | Commentary

The most important challenges ahead of microbiome pattern in the post era of the COVID-19 pandemic

Authors: Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Seyed Davar Siadat, Bagher Larijani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

As the ongoing COVID-19 pandemic posed a huge challenge to global public health, emphasis on personal hygiene caused extraordinary daily use of detergents and household cleaning products. Since antibacterial cleaning products have the capacity to change the environmental microbiome, increased exposure to household disinfectants could be associated with alterations in human microbiota composition and function. Moreover, the emerging links between household cleaning products and occurrence of non-communicable diseases and antibiotic resistance may involve the gut microbiome. The mediating effects of disturbed gut microbiota on associations between home use of cleaning products and life-long health consequences have been documented in some observational studies. Regarding the evidence associated reduction in exposure to non-pathogenic commensal bacteria and gut dysbiosis, further study is required to assess the effect of massive use of cleaning products during COVID-19 pandemic on long-term host health mediated by the altered microbiota. In this context, recommendations to consume probiotics and fermented foods might reverse the consequences by alleviating dysbiosis.
Literature
1.
go back to reference Hui DS, Azhar I, Madani E, Ntoumi TA, Kock F, Dar R, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6. CrossRef Hui DS, Azhar I, Madani E, Ntoumi TA, Kock F, Dar R, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6. CrossRef
3.
go back to reference Xiao Y, Torok ME. Taking the right measures to control COVID-19. Lancet Infect Dis. 2020. Xiao Y, Torok ME. Taking the right measures to control COVID-19. Lancet Infect Dis. 2020.
4.
go back to reference Sanidad KZ, Xiao H, Zhang G. Triclosan, a common antimicrobial ingredient, on gut microbiota and gut health. Gut Microbes. 2019;10(3):434–7. CrossRef Sanidad KZ, Xiao H, Zhang G. Triclosan, a common antimicrobial ingredient, on gut microbiota and gut health. Gut Microbes. 2019;10(3):434–7. CrossRef
5.
go back to reference Jutkina J, Marathe NP, Flach CF, Larsson DGJ. Antibiotics and common antibacterial biocides stimulate horizontal transfer of resistance at low concentrations. Sci Total Environ. 2018;616–617:172–8. CrossRef Jutkina J, Marathe NP, Flach CF, Larsson DGJ. Antibiotics and common antibacterial biocides stimulate horizontal transfer of resistance at low concentrations. Sci Total Environ. 2018;616–617:172–8. CrossRef
6.
go back to reference Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the Hygiene Hypothesis and home hygiene. Clin Exp Allergy. 2006;36(4):402–25. CrossRef Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the Hygiene Hypothesis and home hygiene. Clin Exp Allergy. 2006;36(4):402–25. CrossRef
7.
go back to reference Yee AL, Gilbert JA. Is triclosan harming your microbiome? Science. 2016;353(6297):348–9. CrossRef Yee AL, Gilbert JA. Is triclosan harming your microbiome? Science. 2016;353(6297):348–9. CrossRef
8.
9.
go back to reference Lambeth SM, Carson T, Lowe J, Ramaraj T, Leff JW, Luo L, et al. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes. 2015;2(3):1–7. PubMedPubMedCentral Lambeth SM, Carson T, Lowe J, Ramaraj T, Leff JW, Luo L, et al. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes. 2015;2(3):1–7. PubMedPubMedCentral
10.
go back to reference Gao B, Tu P, Bian X, Chi L, Ru H, Lu K. Profound perturbation induced by triclosan exposure in mouse gut microbiome: a less resilient microbial community with elevated antibiotic and metal resistomes. BMC Pharmacol Toxicol. 2017;18(1):46. CrossRef Gao B, Tu P, Bian X, Chi L, Ru H, Lu K. Profound perturbation induced by triclosan exposure in mouse gut microbiome: a less resilient microbial community with elevated antibiotic and metal resistomes. BMC Pharmacol Toxicol. 2017;18(1):46. CrossRef
11.
go back to reference Wang C, Yu Z, Shi X, Tang X, Wang Y, Wang X, et al. Triclosan enhances the clearing of pathogenic intracellular salmonella or Candida albicans but disturbs the intestinal microbiota through mTOR-independent autophagy. Front Cell Infect Microbiol. 2018;8:49. CrossRef Wang C, Yu Z, Shi X, Tang X, Wang Y, Wang X, et al. Triclosan enhances the clearing of pathogenic intracellular salmonella or Candida albicans but disturbs the intestinal microbiota through mTOR-independent autophagy. Front Cell Infect Microbiol. 2018;8:49. CrossRef
12.
go back to reference Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018;9:1830. Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018;9:1830.
13.
go back to reference Yueh MF, Tukey RH, Triclosan. A widespread environmental toxicant with many biological effects. Annu Rev Pharmacol Toxicol. 2016;56:251–72. CrossRef Yueh MF, Tukey RH, Triclosan. A widespread environmental toxicant with many biological effects. Annu Rev Pharmacol Toxicol. 2016;56:251–72. CrossRef
14.
go back to reference Ma Y, Guo Y, Ye H, Zhang J, Ke Y, et al. Perinatal Triclosan exposure in the rat induces long-term disturbances in metabolism and gut microbiota in adulthood and old age. Environ Res. 2020;182:109004. CrossRef Ma Y, Guo Y, Ye H, Zhang J, Ke Y, et al. Perinatal Triclosan exposure in the rat induces long-term disturbances in metabolism and gut microbiota in adulthood and old age. Environ Res. 2020;182:109004. CrossRef
15.
go back to reference Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB, et al. Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children. CMAJ. 2018;190(45):E1341. CrossRef Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB, et al. Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children. CMAJ. 2018;190(45):E1341. CrossRef
16.
go back to reference Zang L, Ma Y, Huang W, Ling Y, Sun L, Wang X, et al. Dietary Lactobacillus plantarum ST-III alleviates the toxic effects of triclosan on zebrafish (Danio rerio) via gut microbiota modulation. Fish Shellfish Immunol. 2019;84:1157–69. CrossRef Zang L, Ma Y, Huang W, Ling Y, Sun L, Wang X, et al. Dietary Lactobacillus plantarum ST-III alleviates the toxic effects of triclosan on zebrafish (Danio rerio) via gut microbiota modulation. Fish Shellfish Immunol. 2019;84:1157–69. CrossRef
Metadata
Title
The most important challenges ahead of microbiome pattern in the post era of the COVID-19 pandemic
Authors
Hanieh-Sadat Ejtahed
Shirin Hasani-Ranjbar
Seyed Davar Siadat
Bagher Larijani
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00579-0

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.